Related Experiment Video

Updated: Aug 10, 2026

Rapid Generation of Amyloid from Native Proteins In vitro
05:48

Rapid Generation of Amyloid from Native Proteins In vitro

Published on: December 5, 2013

Modified-peptide inhibitors of amyloid beta-peptide polymerization

M A Findeis1, G M Musso, C C Arico-Muendel

  • 1PRAECIS Pharmaceuticals Incorporated, Cambridge, Massachusetts, 02139-1572, USA. mfindeis@ppi.com

Biochemistry
|May 29, 1999
PubMed

Insights

Researchers developed novel peptide inhibitors targeting amyloid beta-peptide (Abeta) polymerization, a key factor in Alzheimer's disease (AD). Optimized peptide analogs demonstrated potent Abeta polymerization inhibition and enhanced stability, offering potential therapeutic strategies for AD.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Medicinal Chemistry

Background:

  • Alzheimer's disease (AD) pathogenesis is strongly linked to amyloid beta-peptide (Abeta) polymerization and subsequent cellular toxicity.
  • Inhibiting Abeta polymerization is a critical therapeutic strategy for AD treatment.
  • The self-affinity of Abeta suggests potential for developing Abeta-specific inhibitors.

Purpose of the Study:

  • To develop novel peptide-based inhibitors targeting Abeta polymerization.
  • To optimize these inhibitors for enhanced potency and biochemical stability.
  • To identify lead compounds for potential AD therapeutics.

Main Methods:

  • Design and synthesis of Abeta-derived peptides.
  • Modification of peptide amino termini to enhance activity.
  • Structure-activity relationship studies to optimize peptide size and sequence.
  • Assessment of polymerization inhibitory activity.
  • Evaluation of biochemical stability in monkey cerebrospinal fluid.

Main Results:

  • Abeta-derived peptides of fifteen residues showed inhibitory activity against Abeta polymerization.
  • Modification of peptide termini enhanced inhibitory activity.
  • Optimization led to a lead compound, cholyl-Leu-Val-Phe-Phe-Ala-OH (PPI-368), with potent inhibition.
  • All-D-amino acyl analogues (PPI-433 and PPI-457) retained activity and exhibited stability in cerebrospinal fluid for 24 hours.

Conclusions:

  • Peptide-based inhibitors can effectively target Abeta polymerization.
  • Structural modifications and the use of all-D-amino acids can improve inhibitor stability and potency.
  • Optimized peptide analogs represent promising candidates for AD therapeutic development.

More Related Videos

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 26, 2016

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis06:17

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis

Published on: May 22, 2018

Related Concept Videos

Peptide Bonds02:43

Peptide Bonds

A peptide bond covalently attaches amino acids through a dehydration reaction. One amino acid's carboxyl group and another amino acid's amino group combine, releasing a water molecule. The resulting bond is the peptide bond. The products that such linkages form are peptides. As more amino acids join this growing chain, the resulting chain is a polypeptide. Each polypeptide has a free amino group at one end. This end has the N-terminal, or the amino-terminal, and the other end has a free...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...